1
views
0
recommends
+1 Recommend
2 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Long COVID and the risk of suicide

      letter
      a , b , c , *
      General Hospital Psychiatry
      Elsevier Inc.
      Long COVID, Suicide, Depression, Mental health, Public health

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Long COVID is a major public health issue around the world [1,2]. Multiple definitions of long COVID exist but the bottom line is that long COVID is a persistent syndrome affecting a significant proportion of patients who had acute COVID-19 [[1], [2], [3]]. University of Washington's Institute for Health Metrics and Evaluation research shows that worldwide, nearly 150 million people are estimated to have developed long COVID during the first two years of the pandemic [2]. Even a mild COVID-19 infection can cause long COVID. To be considered as related to long COVID, complaints had to have appeared or worsened since acute COVID-19 infection and to persist after the acute phase of illness. The clinical spectrum of long COVID is various [1,4]. It includes respiratory, metabolic and neuropsychiatric disorders and pain syndromes. An association between neuropsychiatric complaints and somatic complaints has been observed in patients with long COVID (for example, cognitive complaints and depressed mood with respiratory symptoms) [4]. Depression, anxiety, posttraumatic symptoms, sleep disturbances, fatigue and cognitive deficits are the most frequently reported neuropsychiatric manifestations of long COVID [5]. All these conditions are associated with suicidal ideation and behavior [3,6]. For example, 60% of all individuals who die by suicide have a mood disorder at the time of death. Metabolic and other medical disorders significantly increase suicide risk [7]. For example, diabetes and cardiovascular disorders are associated with elevated risk for suicidal behavior. Also, many studies have shown that chronic pain is an independent risk factor for suicide [8]. Therefore, individuals with long COVID may be at increased risk of suicide. It has also been observed that pre-infection psychosocial distress characterized by depression, anxiety, worry, perceived stress, and loneliness was associated with a substantial increase in the suicide risk among individuals with long COVID [5]. A recent study examined possible association between long COVID, psychiatric symptoms and psychiatric disorders [9]. The authors found that the number of long COVID complaints was higher in patients with significant suicide risk. Respiratory and cognitive complaints and persistent fatigue were more frequent in patients with significant suicide risk than in patients without any psychiatric disorders. The authors also found that cognitive complaints were associated with a significant suicide risk adjusting for age, sex, and ICU stay. A recent meta-analysis showed that some post-COVID patients experience persistent suicidality [10]. Another recent study found that compared with individuals who did not have COVID, those who had COVID were 46% more likely to have suicidal ideation during the post-acute phase [11]. The presence of suicidal ideation increases suicide risk. There are very few publications regarding the relation between long COVID and suicide [3,9,10,11]. This issue does not receive sufficient attention. The goal of this note is to draw attention of the medical community to the risk of suicide in individuals with long COVID. Suicide risk in long COVID may be underappreciated by both mental health and non-mental health medical professionals. Therefore, it is very important to educate medical professionals working with long COVID patients that • individuals with long COVID may be suicidal, • persons with long COVID need to be screened for suicidality, • if necessary, suicide prevention interventions should be implemented. Families of individuals with long COVID need to be educated that psychiatric symptoms especially, suicidal ideation in long COVID patients should be taken seriously. It is necessary to advise families of long COVID patients to get immediate professional medical help if individuals with long COVID experience suicidal thoughts. It is vital to educate policy makers and public health administrators that long COVID may be associated with significant psychiatric issues including suicidal ideation and behavior. Sufficient resources need to be allocated to make sure that long COVID patients with psychiatric symptoms receive appropriate mental health care. Conflict of Interest None.

          Related collections

          Most cited references11

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Risks of mental health outcomes in people with covid-19: cohort study

          Abstract Objective To estimate the risks of incident mental health disorders in survivors of the acute phase of covid-19. Design Cohort study. Setting US Department of Veterans Affairs. Participants Cohort comprising 153 848 people who survived the first 30 days of SARS-CoV-2 infection, and two control groups: a contemporary group (n=5 637 840) with no evidence of SARS-CoV-2, and a historical control group (n=5 859 251) that predated the covid-19 pandemic. Main outcomes measures Risks of prespecified incident mental health outcomes, calculated as hazard ratio and absolute risk difference per 1000 people at one year, with corresponding 95% confidence intervals. Predefined covariates and algorithmically selected high dimensional covariates were used to balance the covid-19 and control groups through inverse weighting. Results The covid-19 group showed an increased risk of incident anxiety disorders (hazard ratio 1.35 (95% confidence interval 1.30 to 1.39); risk difference 11.06 (95% confidence interval 9.64 to 12.53) per 1000 people at one year), depressive disorders (1.39 (1.34 to 1.43); 15.12 (13.38 to 16.91) per 1000 people at one year), stress and adjustment disorders (1.38 (1.34 to 1.43); 13.29 (11.71 to 14.92) per 1000 people at one year), and use of antidepressants (1.55 (1.50 to 1.60); 21.59 (19.63 to 23.60) per 1000 people at one year) and benzodiazepines (1.65 (1.58 to 1.72); 10.46 (9.37 to 11.61) per 1000 people at one year). The risk of incident opioid prescriptions also increased (1.76 (1.71 to 1.81); 35.90 (33.61 to 38.25) per 1000 people at one year), opioid use disorders (1.34 (1.21 to 1.48); 0.96 (0.59 to 1.37) per 1000 people at one year), and other (non-opioid) substance use disorders (1.20 (1.15 to 1.26); 4.34 (3.22 to 5.51) per 1000 people at one year). The covid-19 group also showed an increased risk of incident neurocognitive decline (1.80 (1.72 to 1.89); 10.75 (9.65 to 11.91) per 1000 people at one year) and sleep disorders (1.41 (1.38 to 1.45); 23.80 (21.65 to 26.00) per 1000 people at one year). The risk of any incident mental health diagnosis or prescription was increased (1.60 (1.55 to 1.66); 64.38 (58.90 to 70.01) per 1000 people at one year). The risks of examined outcomes were increased even among people who were not admitted to hospital and were highest among those who were admitted to hospital during the acute phase of covid-19. Results were consistent with those in the historical control group. The risk of incident mental health disorders was consistently higher in the covid-19 group in comparisons of people with covid-19 not admitted to hospital versus those not admitted to hospital for seasonal influenza, admitted to hospital with covid-19 versus admitted to hospital with seasonal influenza, and admitted to hospital with covid-19 versus admitted to hospital for any other cause. Conclusions The findings suggest that people who survive the acute phase of covid-19 are at increased risk of an array of incident mental health disorders. Tackling mental health disorders among survivors of covid-19 should be a priority.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Associations of Depression, Anxiety, Worry, Perceived Stress, and Loneliness Prior to Infection With Risk of Post–COVID-19 Conditions

            This cohort study analyzes self-reported data from 3 large ongoing studies to determine whether high levels of psychological distress before SARS-CoV-2 infection are associated with increased risk of developing post–COVID-19 conditions, sometimes called long COVID.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Chronic pain and suicide risk: A comprehensive review

                Bookmark

                Author and article information

                Journal
                Gen Hosp Psychiatry
                Gen Hosp Psychiatry
                General Hospital Psychiatry
                Elsevier Inc.
                0163-8343
                1873-7714
                5 December 2022
                5 December 2022
                Affiliations
                [a ]James J. Peters VA Medical Center, Bronx, NY, USA
                [b ]Icahn School of Medicine at Mount Sinai, New York, NY, USA
                [c ]Columbia University College of Physicians and Surgeons, New York, NY, USA
                Author notes
                [* ]Corresponding author at: James J. Peters VA Medical Center, 130 West Kingsbridge Road, Bronx, NY 10468, USA.
                Article
                S0163-8343(22)00142-6
                10.1016/j.genhosppsych.2022.12.001
                9721155
                36494289
                38a3afb0-f48e-4492-8470-37f577fa4c89
                © 2022 Elsevier Inc. All rights reserved.

                Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

                History
                : 25 October 2022
                : 30 November 2022
                : 1 December 2022
                Categories
                Letter to the Editor

                long covid,suicide,depression,mental health,public health
                long covid, suicide, depression, mental health, public health

                Comments

                Comment on this article